Almanack Investment Partners, Llc. Novartis Ag Transaction History

Almanack Investment Partners, Llc.

$612 Million
Q3 2024

A detailed history of Almanack Investment Partners, Llc. transactions in Novartis Ag stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 3,010 shares of NVS stock, worth $312,468. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,010

Previous 2,997 0.43%

Holding current value

$312,468

Previous $319,000 8.46%

% of portfolio

0.06%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$106.13 - $120.89 $1,379 - $1,571	13 Added 0.43%	3,010 $346,000
Q2 2024 Aug 09, 2024	BUY	$92.57 - $107.37 $3,054 - $3,543	33 Added 1.11%	2,997 $319,000
Q1 2024 May 01, 2024	BUY	$95.27 - $108.47 $6,668 - $7,592	70 Added 2.42%	2,964 $286,000
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $5,181 - $5,874	56 Added 1.97%	2,894 $292,000
Q4 2022 Feb 08, 2023	BUY	$75.55 - $92.52 $214,410 - $262,571	2,838 New	2,838 $257,000
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $310,485 - $361,500	3,856 New	3,856 $326,000
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $179,179 - $208,451	-2,191 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$85.24 - $94.15 $295,100 - $325,947	-3,462 Reduced 61.24%	2,191 $200,000
Q1 2021 May 11, 2021	BUY	$83.5 - $98.47 $70,975 - $83,699	850 Added 17.7%	5,653 $483,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $132,875 - $160,719	1,702 Added 54.89%	4,803 $454,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $6,653 - $7,371	-81 Reduced 2.55%	3,101 $261,000
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $65,229 - $73,426	-806 Reduced 20.21%	3,182 $278,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $83,885 - $117,524	1,187 Added 42.38%	3,988 $329,000
Q2 2019 Jul 31, 2019	SELL	$75.4 - $92.8 $3,543 - $4,361	-47 Reduced 1.65%	2,801 $0
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $190,645 - $220,520	2,848 New	2,848 $253,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.

Account

Almanack Investment Partners, Llc. Novartis Ag Transaction History